Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Citanest
2. Citanest Octapressin
3. Prilocaine
4. Propitocaine
5. Xylonest
1. 1786-81-8
2. Propitocaine Hydrochloride
3. Prilocaine Hcl
4. Xylonest
5. Citanest Hydrochloride
6. Citanest Plain
7. Prilocaine (hydrochloride)
8. Prilocaine, Hcl
9. Astra 1512
10. N-(2-methylphenyl)-2-(propylamino)propanamide Hydrochloride
11. Mfcd00079279
12. 2-(propylamino)-
13. 878791-35-6
14. L-67
15. N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride
16. Mjw015baph
17. 2-(propylamino)-m-propionotoluidide Hydrochloride
18. 2-(propylamino)-o-propionotoluidide Hydrochloride
19. Nsc-758432
20. Mls000069690
21. Propanamide, N-(2-methylphenyl)-2-(propylamino)-, Monohydrochloride
22. Prilocaine Chloride
23. Smr000058506
24. Propanamide, N-(2-methylphenyl)-2-(propylamino)-, Hydrochloride (1:1)
25. 2-(propylamino)-o-propionotoluidide Monohydrochloride
26. Alpha-propylamine-2-methyl-propionanilide Hydrochloride
27. Dsstox_cid_11956
28. Dsstox_rid_78897
29. Dsstox_gsid_31956
30. Propitocaine Hydrochloride (jan)
31. Propitocaine Hydrochloride [jan]
32. Chebi:32053
33. Prilocaine Hydrochloride [usan]
34. Sr-01000076094
35. Einecs 217-244-0
36. Unii-mjw015baph
37. 2-(propylamino)-n-(o-tolyl)propanamide Hydrochloride
38. Citanest (tn)
39. Prestwick_616
40. Prilocaine Hydrochloride [usan:usp]
41. O-propionotoluidide, 2-(propylamino)-, Monohydrochloride
42. Propitocainehydrochloride
43. Opera_id_480
44. Ncgc00016594-01
45. Cas-1786-81-8
46. L-67 Hydrochloride
47. Dl-(+-)-prilocaine Hcl
48. Mls002222230
49. Mls002548864
50. Schembl330180
51. Spectrum1503270
52. 2-(propylamino)-n-(o-tolyl)propionamide Hydrochloride
53. Amy587
54. Prilocaine Hydrochloride (usp)
55. Chembl1200586
56. Dtxsid2031956
57. Niosh/tx1480000
58. Hy-b0137a
59. Dl-(+-)-prilocaine Hydrochloride
60. Hms1568h19
61. Hms1922o15
62. Pharmakon1600-01503270
63. Prilocaine Hcl (propitocaine Hcl)
64. Act04757
65. Bcp22337
66. Ex-a2857
67. Tox21_110513
68. Tox21_501005
69. Ccg-39327
70. Nsc758432
71. Prilocaine Hydrochloride [mi]
72. S5482
73. Akos015895106
74. Tox21_110513_1
75. Ac-2099
76. Cs-1930
77. Ks-5024
78. Lp01005
79. Nc00474
80. Nsc 758432
81. Prilocaine Hydrochloride [mart.]
82. Prilocaine Hydrochloride [vandf]
83. Ncgc00015860-06
84. Ncgc00094299-01
85. Ncgc00094299-02
86. Ncgc00094299-03
87. Ncgc00094299-04
88. Ncgc00094299-05
89. Ncgc00261690-01
90. Prilocaine Hydrochloride [usp-rs]
91. Prilocaine Hydrochloride [who-dd]
92. Bp166249
93. Prilocaine Hydrochloride, >=98% (tlc)
94. Sy066795
95. Bcp0726000006
96. Eu-0101005
97. Ft-0633840
98. P2038
99. Tx14800000
100. Prilocaine Hydrochloride [ep Impurity]
101. Prilocaine Hydrochloride [orange Book]
102. D01243
103. P 9547
104. Prilocaine Hydrochloride [ep Monograph]
105. Prilocaine Hydrochloride [usp Monograph]
106. 2-(propylamino)-n-o-tolylpropanamide Hydrochloride
107. 786p818
108. A812391
109. Q-201619
110. Sr-01000076094-1
111. Sr-01000076094-6
112. N-(2-methylphenyl)-n2-propylalaninamide Hydrochloride
113. Q27114764
114. Prilocaine Hydrochloride, Meets Usp Testing Specifications
115. O-propionotoluidide, 2-(propylamino)-, Hydrochloride, (+-)-
116. (+-)-n-(2-methylphenyl)-2-(propylamino)propanamide Hydrochloride
117. N-(2-methylphenyl)-2-(propylamino)propanamide Hydrochloride (1:1)
118. Prilocaine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
119. Propanamide, N-(2-methylphenyl)-2-(propylamino)-, Hydrochloride, (+-)-
120. Prilocaine For Peak Identification, European Pharmacopoeia (ep) Reference Standard
121. Prilocaine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 256.77 g/mol |
---|---|
Molecular Formula | C13H21ClN2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 256.1342410 g/mol |
Monoisotopic Mass | 256.1342410 g/mol |
Topological Polar Surface Area | 41.1 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 218 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Prilocaine hydrochloride |
Drug Label | Prilocaine Hydrochloride Injection, USP, 4% is a sterile, non pyrogenic isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The quantitative composition... |
Active Ingredient | Prilocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 4% |
Market Status | Prescription |
Company | Septodont |
2 of 2 | |
---|---|
Drug Name | Prilocaine hydrochloride |
Drug Label | Prilocaine Hydrochloride Injection, USP, 4% is a sterile, non pyrogenic isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The quantitative composition... |
Active Ingredient | Prilocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 4% |
Market Status | Prescription |
Company | Septodont |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Prilocaine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prilocaine Hydrochloride, including repackagers and relabelers. The FDA regulates Prilocaine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prilocaine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prilocaine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prilocaine Hydrochloride supplier is an individual or a company that provides Prilocaine Hydrochloride active pharmaceutical ingredient (API) or Prilocaine Hydrochloride finished formulations upon request. The Prilocaine Hydrochloride suppliers may include Prilocaine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Prilocaine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Prilocaine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Prilocaine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Prilocaine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Prilocaine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Prilocaine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Prilocaine Hydrochloride USDMF includes data on Prilocaine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prilocaine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Prilocaine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Prilocaine Hydrochloride Drug Master File in Japan (Prilocaine Hydrochloride JDMF) empowers Prilocaine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Prilocaine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Prilocaine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Prilocaine Hydrochloride suppliers with JDMF on PharmaCompass.
A Prilocaine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Prilocaine Hydrochloride Certificate of Suitability (COS). The purpose of a Prilocaine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prilocaine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prilocaine Hydrochloride to their clients by showing that a Prilocaine Hydrochloride CEP has been issued for it. The manufacturer submits a Prilocaine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prilocaine Hydrochloride CEP holder for the record. Additionally, the data presented in the Prilocaine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prilocaine Hydrochloride DMF.
A Prilocaine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prilocaine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Prilocaine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Prilocaine Hydrochloride written confirmation (Prilocaine Hydrochloride WC) is an official document issued by a regulatory agency to a Prilocaine Hydrochloride manufacturer, verifying that the manufacturing facility of a Prilocaine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prilocaine Hydrochloride APIs or Prilocaine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Prilocaine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Prilocaine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prilocaine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Prilocaine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Prilocaine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Prilocaine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prilocaine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Prilocaine Hydrochloride suppliers with NDC on PharmaCompass.
Prilocaine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prilocaine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prilocaine Hydrochloride GMP manufacturer or Prilocaine Hydrochloride GMP API supplier for your needs.
A Prilocaine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Prilocaine Hydrochloride's compliance with Prilocaine Hydrochloride specifications and serves as a tool for batch-level quality control.
Prilocaine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Prilocaine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prilocaine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Prilocaine Hydrochloride EP), Prilocaine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prilocaine Hydrochloride USP).
LOOKING FOR A SUPPLIER?